ACHP - healthylife7.com

Cancer, rare disease dominate FDA approvals in H1 2026 as AstraZeneca, J&J clean up

By stamilhstgr0518@gmail.comJuly 9, 20260

Amid unprecedented leadership uncertainty, workforce attrition and myriad controversial decisions, the FDA approved 26 novel drugs in the first half of 2026—seven more than its H1 2025 total

What's Hot

Cancer, rare disease dominate FDA approvals in H1 2026 as AstraZeneca, J&J clean up

Graduate of Doctor of Health Sciences Graduate Program has Research Published, Selected for National Presentation

Experts Reveal Lifestyle Factors Fueling Multiple Sclerosis As Christina Applegate And Selma Blair Struggle

Browsing: ACHP

ACHP Forms Patient Advisory Council to Elevate Patient Voices in Chronic Disease Research

Cancer, rare disease dominate FDA approvals in H1 2026 as AstraZeneca, J&J clean up

Graduate of Doctor of Health Sciences Graduate Program has Research Published, Selected for National Presentation

Experts Reveal Lifestyle Factors Fueling Multiple Sclerosis As Christina Applegate And Selma Blair Struggle

The Secret to Crushing Your Next Hot

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

Fitness

Cancer, rare disease dominate FDA approvals in H1 2026 as AstraZeneca, J&J clean up

Graduate of Doctor of Health Sciences Graduate Program has Research Published, Selected for National Presentation

Experts Reveal Lifestyle Factors Fueling Multiple Sclerosis As Christina Applegate And Selma Blair Struggle

Health

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

Subscribe to Updates

What's Hot

Browsing: ACHP